ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 971

B Cell ROCK1 Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity

Edd Ricker1, Danny Flores-Castro 2, Sanjay Gupta 3, Andrew Cheng 3, Yurii Chinenov 3, Tania Pannellini 2, Young-Bum Kim 4 and Alessandra Pernis 5, 1Hospital for Special Surgery, New York, NY, 2Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, 3Hospital for Special Surgery, New York, 4Beth Israel Deaconess Medical Center, Boston, MA, 51.Autoimmunity and Inflammation Program, Hospital for Special Surgery. 2.David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery. 3.Department of Medicine, Weill Cornell Medical College, Cornell University, New York

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: adaptive immunity and Cell Signaling, B cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: B Cell Biology & Targets In Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rho GTPases, such as RhoA, have emerged as important regulators of lymphocyte biology owing to their ability to be rapidly activated downstream of a broad range of signals. Two of the major effectors of RhoA signaling are the Rho Kinases (ROCKs), ROCK1 and ROCK2, a pair of serine-threonine kinases that have been previously implicated in the control of cell adhesion, migration, proliferation/survival, and gene expression. Despite the fundamental reliance of T and B cells on these processes, the precise involvement of the ROCKs in lymphocyte biology is yet to be elucidated. Here, we investigate the contribution of ROCK1 to B cell development and differentiation following immunization with a T-dependent antigen.

Methods: To assess the roles of B cell ROCK1 in T cell-dependent responses, mice with B cell-specific deletions of ROCK1 (CD23-Cre.Rock1flox/flox and Cγ-Cre.Rock1flox/flox mice) were immunized with a T-dependent antigen. Rock1flox/flox mice were also immunized as a control for this study. The differentiation of germinal center (GC) B cells and plasmablast/plasma cells (PB/PCs) was monitored by FACS at various timepoints following immunization. Total and antigen-specific antibody responses were also assessed by ELISA. The molecular mechanisms employed by ROCK1 to promote B cell differentiation were further examined by FACS-sorting B cell populations from spleens of immunized mice followed by RNA-sequencing analyses.

Results: We found that ROCK1 is expressed and activated in splenic B cells. Mice with B cell-specific deletion of ROCK1 showed marked reductions in total and antigen-specific antibody responses following immunization. These decreased humoral responses corresponded with impaired formation and maintenance of antigen-specific GC B cells and PB/PCs following immunization in the ROCK1-deficient mice. Through next generation sequencing, we have furthermore identified a ROCK1-regulated transcriptional program that supports the phenotype of GC B cells.

Conclusion: Our study demonstrates that ROCK1 is activated in B cells and is required for the optimal development of mature B cell populations at baseline and for efficient GC responses following immunization. These findings thus uncover previously unknown B cell-specific roles for ROCK1 in promoting humoral responses and suggests that targeting ROCK1 activity may provide therapeutic benefit for the treatment of diseases marked by aberrant B cell responses.


Disclosure: E. Ricker, None; D. Flores-Castro, None; S. Gupta, None; A. Cheng, None; Y. Chinenov, None; T. Pannellini, None; Y. Kim, None; A. Pernis, Kadmon pharmaceutical, 2.

To cite this abstract in AMA style:

Ricker E, Flores-Castro D, Gupta S, Cheng A, Chinenov Y, Pannellini T, Kim Y, Pernis A. B Cell ROCK1 Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/b-cell-rock1-promotes-germinal-center-responses-and-is-required-for-optimal-humoral-immunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-rock1-promotes-germinal-center-responses-and-is-required-for-optimal-humoral-immunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology